Clinical Trials

Status
Title Intervention Sponsor Status
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients Biospecimen Collection, HPV Self-Collection, Questionnaire Administration, Recombinant Human Papillomavirus Nonavalent Vaccine National Cancer Institute (NCI) Active, not recruiting
Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast Afimoxifene, Laboratory Biomarker Analysis, Placebo, Tamoxifen Citrate Northwestern University Recruiting
Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer Biospecimen Collection, Retinoid 9cUAB30, Therapeutic Conventional Surgery National Cancer Institute (NCI) Active, not recruiting
Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission Laboratory Biomarker Analysis, Sargramostim, pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine University of Washington Active, not recruiting
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine National Cancer Institute (NCI) Active, not recruiting